Australian scientists believe they have identified an enzyme that causes dysfunction in the three major diabetes players: the pancreas, the liver and muscle. Known as ‘NIK kinase’, the enzyme activates a signalling pathway that affects many genes, switching some on and others off. Associate Professor Shane T. Grey and Dr Elizabeth Malle, from Sydney’s Garvan
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.